Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Jun 2025 for REGENXBIO Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
David C. Stump: trading record in brief
Filings by David C. Stump span 2 companies, the busiest being REGENXBIO Inc. and Macrogenics Inc. The record holds 6 filings, for trades running from 3 June 2022 to 30 May 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 3 June 2025, the filings show a share grant in REGENXBIO Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to David C. Stump
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
7,768 shares0Common StockSEC:0001562180-25-004352:0
6,500 sharesCommon StockSEC:0001125345-25-000081:0
4,790 shares0Common StockSEC:0001562180-24-004649:0
4,500 shares0Common StockSEC:0001125345-24-000106:0
3,486 shares0Common StockSEC:0001562180-23-004893:0
3,010 shares0Common StockSEC:0001562180-22-004880:0
6 of 6 declarations
